Cargando…
GSK3 and p53 - is there a link in Alzheimer's disease?
BACKGROUND: Recent evidence suggests that glycogen synthase kinase-3β (GSK3β) is implicated in both sporadic and familial forms of Alzheimer's disease. The transcription factor, p53 also plays a role and has been linked to an increase in tau hyperphosphorylation although the effect is indirect....
Autores principales: | Proctor, Carole J, Gray, Douglas A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831894/ https://www.ncbi.nlm.nih.gov/pubmed/20181016 http://dx.doi.org/10.1186/1750-1326-5-7 |
Ejemplares similares
-
Explaining oscillations and variability in the p53-Mdm2 system
por: Proctor, Carole J, et al.
Publicado: (2008) -
A Unifying Hypothesis for Familial and Sporadic Alzheimer's Disease
por: Proctor, Carole J., et al.
Publicado: (2012) -
Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
por: Proctor, Carole J., et al.
Publicado: (2013) -
The GSK3 hypothesis of Alzheimer's disease
por: Hooper, Claudie, et al.
Publicado: (2008) -
GSK3 and Alzheimer’s Disease: Facts and Fiction…
por: Kremer, Anna, et al.
Publicado: (2011)